• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下调 VEGFR3 信号会改变心脏淋巴管的组织,导致急性心肌梗死后的死亡率升高。

Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction.

机构信息

A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211, Kuopio, Finland.

Research Unit of Medical Imaging, Physics and Technology, University of Oulu, Oulu, Finland.

出版信息

Sci Rep. 2018 Nov 12;8(1):16709. doi: 10.1038/s41598-018-34770-4.

DOI:10.1038/s41598-018-34770-4
PMID:30420641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6232169/
Abstract

Heart has a wide lymphatic network but the importance of cardiac lymphatic system in heart diseases has remained unclear. Vascular Endothelial Growth Factor Receptor 3 (VEGFR3) is a key molecule in the development and maintenance of cardiac lymphatic vessels. Here we characterized the role of VEGFR3 in healthy hearts and after myocardial infarction (MI) by using sVEGFR3 transgenic mice expressing a soluble decoy VEGFR3 under K14 promoter and Chy mice which have an inactivating mutation in the VEGFR3 gene. Cardiac lymphatic vessels were significantly dilated in the healthy hearts of sVEGFR3 mice when compared to controls. Lymphatic vessels formed large sheet-like structures in Chy mice. Attenuated VEGFR3 signaling led to a more severe MI predisposing to a significantly higher mortality in sVEGFR3 mice than in control mice. sVEGFR3 mice displayed intramyocardial hemorrhages in the infarcted area indicating hyperpermeability of the vasculature. Furthermore, novel MRI methods TRAFF2 and TRAFF4 and histological analysis revealed a modified structure of the fibrotic infarcted area in sVEGFR3 mice. In conclusion, the downregulation of VEGFR3 signaling modifies the structure of cardiac lymphatic network and causes vascular leakiness and increased mortality after MI.

摘要

心脏具有广泛的淋巴网络,但心脏淋巴系统在心脏病中的重要性仍不清楚。血管内皮生长因子受体 3(VEGFR3)是心脏淋巴管发育和维持的关键分子。在这里,我们通过使用在 K14 启动子下表达可溶性诱饵 VEGFR3 的 sVEGFR3 转基因小鼠和具有 VEGFR3 基因失活突变的 Chy 小鼠,来表征 VEGFR3 在健康心脏和心肌梗死(MI)后的作用。与对照组相比,sVEGFR3 小鼠的心脏淋巴管在健康心脏中明显扩张。淋巴管在 Chy 小鼠中形成大片状结构。VEGFR3 信号的减弱导致 MI 倾向增加,sVEGFR3 小鼠的死亡率明显高于对照组小鼠。sVEGFR3 小鼠在梗死区域显示出心肌内出血,表明血管通透性增加。此外,新型 MRI 方法 TRAFF2 和 TRAFF4 以及组织学分析显示,sVEGFR3 小鼠的纤维化梗死区域的结构发生了改变。总之,VEGFR3 信号的下调改变了心脏淋巴管网络的结构,并导致 MI 后血管渗漏和死亡率增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/7d15aabe4f92/41598_2018_34770_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/5ef7ceae1e85/41598_2018_34770_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/7db6ad76f1af/41598_2018_34770_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/c6e575ae9766/41598_2018_34770_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/9b62b3e52c20/41598_2018_34770_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/c36ef39f386a/41598_2018_34770_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/97f706fb0415/41598_2018_34770_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/7d15aabe4f92/41598_2018_34770_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/5ef7ceae1e85/41598_2018_34770_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/7db6ad76f1af/41598_2018_34770_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/c6e575ae9766/41598_2018_34770_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/9b62b3e52c20/41598_2018_34770_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/c36ef39f386a/41598_2018_34770_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/97f706fb0415/41598_2018_34770_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5749/6232169/7d15aabe4f92/41598_2018_34770_Fig7_HTML.jpg

相似文献

1
Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction.下调 VEGFR3 信号会改变心脏淋巴管的组织,导致急性心肌梗死后的死亡率升高。
Sci Rep. 2018 Nov 12;8(1):16709. doi: 10.1038/s41598-018-34770-4.
2
VE-Cadherin Is Required for Cardiac Lymphatic Maintenance and Signaling.VE-钙黏蛋白对于心脏淋巴管的维持和信号传递是必需的。
Circ Res. 2022 Jan 7;130(1):5-23. doi: 10.1161/CIRCRESAHA.121.318852. Epub 2021 Nov 18.
3
Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction.淋巴和免疫细胞相互作用调控实验性心肌梗死后的心脏恢复。
Arterioscler Thromb Vasc Biol. 2020 Jul;40(7):1722-1737. doi: 10.1161/ATVBAHA.120.314370. Epub 2020 May 14.
4
Lymphatic insufficiency leads to distinct myocardial infarct content assessed by magnetic resonance T, T and T relaxation times.淋巴功能不全导致通过磁共振 T、T 和 T 弛豫时间评估的心肌梗死含量不同。
Sci Rep. 2023 Jan 28;13(1):1579. doi: 10.1038/s41598-023-28219-6.
5
H-, N- and Kras cooperatively regulate lymphatic vessel growth by modulating VEGFR3 expression in lymphatic endothelial cells in mice.H、N 和 Kras 通过调节小鼠淋巴管内皮细胞中 VEGFR3 的表达协同调控淋巴管生长。
Development. 2010 Mar;137(6):1003-13. doi: 10.1242/dev.043489.
6
Functions and Regeneration of Mature Cardiac Lymphatic Vessels in Atherosclerosis, Myocardial Infarction, and Heart Failure.成熟心脏淋巴管在动脉粥样硬化、心肌梗死和心力衰竭中的功能与再生
Lymphat Res Biol. 2018 Dec;16(6):507-515. doi: 10.1089/lrb.2018.0023. Epub 2018 Oct 19.
7
The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.VEGF-C/VEGFR3 信号通路通过激活淋巴管功能有助于解决慢性皮肤炎症。
J Dermatol Sci. 2014 Feb;73(2):135-41. doi: 10.1016/j.jdermsci.2013.10.006. Epub 2013 Oct 29.
8
Identification of ILK as a critical regulator of VEGFR3 signalling and lymphatic vascular growth.鉴定 ILK 作为 VEGFR3 信号和淋巴管生长的关键调节因子。
EMBO J. 2019 Jan 15;38(2). doi: 10.15252/embj.201899322. Epub 2018 Dec 5.
9
Molecular controls of lymphatic VEGFR3 signaling.淋巴管内皮 VEGFR3 信号的分子调控
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):421-9. doi: 10.1161/ATVBAHA.114.304881. Epub 2014 Dec 18.
10
Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.肿瘤坏死因子超家族成员15(Tnfsf15)通过上调淋巴管内皮细胞中Vegfr3基因的表达促进淋巴管生成。
J Pathol. 2015 Nov;237(3):307-18. doi: 10.1002/path.4577. Epub 2015 Aug 6.

引用本文的文献

1
Capturing Acute and Subchronic Myocardial Infarct by MRI Rotating Frame Relaxation Times in Mice In and Ex Vivo.通过MRI旋转框架弛豫时间在体内和体外捕获小鼠急性和亚慢性心肌梗死
NMR Biomed. 2025 Jun;38(6):e70061. doi: 10.1002/nbm.70061.
2
sVEGFR3 alleviates myocardial ischemia/reperfusion injury through regulating mitochondrial homeostasis and immune cell infiltration.可溶性血管内皮生长因子受体3通过调节线粒体稳态和免疫细胞浸润减轻心肌缺血/再灌注损伤。
Apoptosis. 2025 Apr;30(3-4):894-911. doi: 10.1007/s10495-024-02068-8. Epub 2025 Jan 25.
3
Tissue-Engineered Therapeutics for Lymphatic Regeneration: Solutions for Myocardial Infarction and Secondary Lymphedema.

本文引用的文献

1
The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction.心脏淋巴系统可刺激心肌梗死后炎症的消退。
J Clin Invest. 2018 Aug 1;128(8):3402-3412. doi: 10.1172/JCI97192. Epub 2018 Jul 9.
2
Quantification of myocardial infarct area based on T relaxation time maps - comparison with cardiovascular magnetic resonance late gadolinium enhancement, T and T in vivo.基于 T 弛豫时间图的心肌梗死面积定量 - 与心血管磁共振晚期钆增强、T 及体内 T 的比较。
J Cardiovasc Magn Reson. 2018 Jun 7;20(1):34. doi: 10.1186/s12968-018-0463-x.
3
The follow-up of progressive hypertrophic cardiomyopathy using magnetic resonance rotating frame relaxation times.
用于淋巴再生的组织工程疗法:心肌梗死和继发性淋巴水肿的解决方案
Adv Healthc Mater. 2025 Mar;14(6):e2403551. doi: 10.1002/adhm.202403551. Epub 2025 Jan 13.
4
Disease-Specific Alteration of Cardiac Lymphatics: A Review from Animal Disease Models to Clinics.心脏淋巴管疾病特异性改变:从动物疾病模型到临床的综述。
Int J Mol Sci. 2024 Oct 3;25(19):10656. doi: 10.3390/ijms251910656.
5
Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.核心蛋白聚糖抑制肿瘤淋巴管生成:一种抑制癌症进展的机制。
Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2317760121. doi: 10.1073/pnas.2317760121. Epub 2024 Apr 23.
6
Lymphangiogenesis: A new strategy for heart disease treatment (Review).淋巴管生成:心脏病治疗的新策略(综述)。
Int J Mol Med. 2024 Apr;53(4). doi: 10.3892/ijmm.2024.5359. Epub 2024 Feb 23.
7
Role of Lymphangiogenesis in Cardiac Repair and Regeneration.淋巴管生成在心脏修复和再生中的作用。
Methodist Debakey Cardiovasc J. 2023 Nov 16;19(5):37-46. doi: 10.14797/mdcvj.1286. eCollection 2023.
8
Angiogenesis-An Emerging Role in Organ Fibrosis.血管生成——在器官纤维化中的新作用。
Int J Mol Sci. 2023 Sep 15;24(18):14123. doi: 10.3390/ijms241814123.
9
Mechanisms regulating vascular and lymphatic regeneration in the heart after myocardial infarction.心肌梗死后心脏中血管和淋巴管再生的调节机制。
J Pathol. 2023 Aug;260(5):666-678. doi: 10.1002/path.6093. Epub 2023 Jun 5.
10
The Lymphatic Vasculature in Cardiac Development and Ischemic Heart Disease.心脏发育和缺血性心脏病中的淋巴管脉管系统。
Circ Res. 2023 Apr 28;132(9):1246-1253. doi: 10.1161/CIRCRESAHA.122.321672. Epub 2023 Apr 27.
利用磁共振旋转框架弛豫时间对进行性肥厚型心肌病的随访研究
NMR Biomed. 2018 Feb;31(2). doi: 10.1002/nbm.3871. Epub 2017 Dec 15.
4
Cardiac Lymphatic Vessels, Transport, and Healing of the Infarcted Heart.心脏淋巴管、梗死心脏的转运与愈合
JACC Basic Transl Sci. 2017 Aug;2(4):477-483. doi: 10.1016/j.jacbts.2017.02.005. Epub 2017 Aug 28.
5
Adenoviral intramyocardial VEGF-DΔNΔC gene transfer increases myocardial perfusion reserve in refractory angina patients: a phase I/IIa study with 1-year follow-up.腺病毒心肌内 VEGF-DΔNΔC 基因转移增加难治性心绞痛患者的心肌血流储备:一项 1 年随访的 I/IIa 期研究。
Eur Heart J. 2017 Sep 1;38(33):2547-2555. doi: 10.1093/eurheartj/ehx352.
6
VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.血管内皮生长因子受体3通过控制血管内皮生长因子/血管内皮生长因子受体2信号传导来调节血管通透性。
Circ Res. 2017 Apr 28;120(9):1414-1425. doi: 10.1161/CIRCRESAHA.116.310477. Epub 2017 Mar 15.
7
Emerging Roles of Lymphatic Vasculature in Immunity.淋巴管系统在免疫中的新作用
Immune Netw. 2017 Feb;17(1):68-76. doi: 10.4110/in.2017.17.1.68. Epub 2017 Feb 23.
8
Cardiac Lymphatics - A New Avenue for Therapeutics?心脏淋巴管——治疗的新途径?
Trends Endocrinol Metab. 2017 Apr;28(4):285-296. doi: 10.1016/j.tem.2016.12.002. Epub 2017 Jan 10.
9
Lymphatic network in atherosclerosis: the underestimated path.动脉粥样硬化中的淋巴网络:被低估的途径。
Future Sci OA. 2015 Nov 1;1(4):FSO61. doi: 10.4155/fso.15.61. eCollection 2015 Nov.
10
Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration.心肌梗死中的心脏纤维化——从修复、重塑到再生
Cell Tissue Res. 2016 Sep;365(3):563-81. doi: 10.1007/s00441-016-2431-9. Epub 2016 Jun 21.